Inventor
CHEN SHIEH-SHUNG T
US46 patents
⚠️ This page may combine multiple inventors who share the name “CHEN SHIEH-SHUNG T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
45 patentsUS5427933AJun 27, 1995
Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
MERCK & CO INC93 citations96
US5491077AFeb 13, 1996
Microbial method
MERCK & CO INC92 citations95
US5085992AFeb 4, 1992
Microbial transformation process for antihypertensive products
MERCK & CO INC51 citations95
US5198421AMar 30, 1993
Phosphorylated cyclic lipopeptide
MERCK & CO INC34 citations92
US5185251AFeb 9, 1993
Microbial transformation of a substituted pyridinone using actinoplanacete sp. MA 6559
MERCK & CO INC41 citations92
US5053329AOct 1, 1991
Process for preparation of novel angiotensin II antagonists
MERCK & CO INC26 citations92
US5049565ASep 17, 1991
Microbial transformation process for preparing anti-hypertensive products
MERCK & CO INC29 citations92
US4981792AJan 1, 1991
Immunosuppressant compound
MERCK & CO INC34 citations92
US5302604AApr 12, 1994
Cholesterol lowering compounds produced by directed biosynthesis
MERCK & CO INC50 citations91
US5087702AFeb 11, 1992
Microbial transformation process for producing an antihypertensive product
MERCK & CO INC21 citations82
US5149701ASep 22, 1992
C-31 methylated FR-900520 cyclic hemiketal immunosuppressant agents
MERCK & CO INC20 citations81
US5066586ANov 19, 1991
Process for preparation of novel angiotensin II antagonists
MERCK & CO INC19 citations81
US5057522AOct 15, 1991
Anti-hypersensitive N2-tetrazole-β-glucuronide analog
MERCK & CO INC21 citations81
US4987139AJan 22, 1991
FK-520 microbial transformation product
MERCK & CO INC19 citations81
US5290772AMar 1, 1994
Immunosuppressant agent
MERCK & CO INC7 citations73
US5210030AMay 11, 1993
Process for selectively acylating immunomycin
MERCK & CO INC16 citations73
US5132216AJul 21, 1992
Microbial transformation process for antihypertensive products
MERCK & CO INC14 citations73
US5070015ADec 3, 1991
Novel avermectins are produced from known microorganisms
MERCK & CO INC8 citations73
US4975372ADec 4, 1990
Microbial transformation product of L-683,590
MERCK & CO INC8 citations73
US5352783AOct 4, 1994
Microbial transformation product having immunosuppressive activity
MERCK & CO INC14 citations72
US5250563AOct 5, 1993
Inhibitors of HIV protease
MERCK & CO INC15 citations72
US5273979ADec 28, 1993
C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
MERCK & CO INC8 citations71
US5221625AJun 22, 1993
Cyclcic FR-900520 microbial biotransformation agent
MERCK & CO INC14 citations71
US5218125AJun 8, 1993
Antihypertensive compound and method of use thereas
MERCK & CO INC9 citations71
US5214153AMay 25, 1993
Actinoplanes transformation process anti-hypertensive compound and method of use thereas
MERCK & CO INC6 citations71
US5217882AJun 8, 1993
Microbial transformation process for producing antihypertensive N2 -glucuronide products
MERCK & CO INC4 citations63
US5164389ANov 17, 1992
Anthelmintic bioconversion products
MERCK & CO INC4 citations63
US5015662AMay 14, 1991
Anthelmintic bioconversion products
MERCK & CO INC2 citations63
US5270187ADec 14, 1993
Microbial transformation product
MERCK & CO INC2 citations62
US5268370ADec 7, 1993
Microbial transformation product of L-679,934
MERCK & CO INC2 citations62
US5252612AOct 12, 1993
Microbial immunosoppressant agent
MERCK & CO INC3 citations62
US5250422AOct 5, 1993
Biotransformation process for the production of invermectin derivatives
MERCK & CO INC2 citations62
US5138052AAug 11, 1992
L-683,590 microbial transformation product
MERCK & CO INC4 citations62
US5612217AMar 18, 1997
Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitors
MERCK & CO INC4 citations61
US5468771ANov 21, 1995
Cholesterol lowering compound
MERCK & CO INC2 citations61
US5270332ADec 14, 1993
Cholesteral lowering agents
MERCK & CO INC3 citations61
US5202258AApr 13, 1993
Immunosuppressant-producing culture
MERCK & CO INC2 citations61
US5294627AMar 15, 1994
Directed biosynthesis of biologically active compounds
MERCK & CO INC2 citations57
US5283183AFeb 1, 1994
Cyclic FR-900520 microbial biotransformation agent
MERCK & CO INC1 citations52
US5268282ADec 7, 1993
Cyclic FR-900520 microbial biotransformation agent
MERCK & CO INC0 citations52
US5359096AOct 25, 1994
Cholesterol lowering compounds
MERCK & CO INC0 citations51
US5215900AJun 1, 1993
Microbial transformation of a substituted pyridinone using streptomyces sp. MA6804
MERCK & CO INC0 citations51
US5290689AMar 1, 1994
New cyclic FR-900520 microbial biotransformation agent
MERCK & CO INC1 citations49
US5268281ADec 7, 1993
Cyclic FR-900520 microbial biotransformation agent
MERCK & CO INC0 citations49
US5198358AMar 30, 1993
Microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
MERCK & CO INC1 citations49